Market Eye

Market Eye is a leading Australian investor relations and strategic advisory firm that specializes in the life sciences, biotechnology, and technology sectors. Founded in 2007 and acquired by Automic Group in 2022, the company provides equity capital markets advice, shareholder analytics, and media strategies to numerous ASX-listed healthcare companies. While it does not develop its own therapeutic pipeline, it is a key service provider in the biotech ecosystem, often serving as the primary point of contact for investor communications for clinical-stage companies. The firm is well-regarded for its deep market intelligence and proprietary technology solutions tailored for listed entities in the healthcare space.